LifeSci Capital initiated coverage of Tourmaline Bio (TRML) with an Outperform rating and $58 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on TRML: Tourmaline Bio management to meet with Truist Tourmaline Bio management to meet with Cantor Fitzgerald Tourmaline Bio appoints Ridker to Scientific Advisory Board